GF
CMTA

Gabelli Funds’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Gabelli Funds’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-266,780
Closed -$6.96M – 1213
2019
Q1 		$6.96M Buy
+266,780
New +$4.98M 0.04% 440

Gabelli Funds's CMTA Position: Q2 2019 in Review

Gabelli Funds sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 266,780 shares — an estimated $6.96M sold.

Gabelli Funds first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $6.96M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Gabelli Funds reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Gabelli Funds sold 266,780 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $6.96M.
  • Gabelli Funds first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Gabelli Funds's Clementia Pharmaceuticals Inc. position peaked at $6.96M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.